Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06335953 · ClinicalTrials.gov registry record · NA
ALIGN: Aligning Medications With What Matters Most (Demonstration)
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT06335953: Completed NA study, sponsored by Johns Hopkins University.
NCT06335953 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06335953, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the effectiveness of a pharmacist-led, primary care-based de-prescribing intervention for people living with dementia (PLWD) and the person's care partners. The intervention consists of the following strategies: 1) a de-prescribing educational brochure designed to activate the patient and care partner; 2) a single telehealth visit in which an embedded clinical pharmacist discusses the benefits and harms of the patient's medications with the patient and care partner in the context of the person's goals and preferences; and 3) pharmacist-PCP communication in which the pharmacist provides tailored de-prescribing recommendations designed to be useful and actionable for the PCP. The investigators will compare the intervention group with the waitlist control group to see if there is a difference in the primary outcome, the proportion of patients who deprescribe at least one medication by 3 months.
Interventions
- BEHAVIORAL Pharmacist-led deprescribing intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2025-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06335953
The ClinicalTrials.gov registry entry for NCT06335953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-led deprescribing intervention is the first listed.
NCT06335953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06335953 about?
NCT06335953 is a clinical study titled "ALIGN: Aligning Medications With What Matters Most (Demonstration)". The goal of this clinical trial is to test the effectiveness of a pharmacist-led, primary care-based de-prescribing intervention for people living with dementia (PLWD) and the person's care partners. The intervention consists of the following strategies: 1) a de-prescribing educational brochure des...
What is the current status of trial NCT06335953?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2024-05-07. Estimated completion is 2025-10-18.
What interventions are being tested in trial NCT06335953?
The interventions under investigation include: Pharmacist-led deprescribing intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06335953?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.